# A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen

> **NCT00427661** · NA · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 8 (actual)

## Conditions studied

- Sickle Cell Disease
- Thalassemia
- Hemoglobinopathies

## Interventions

- **OTHER:** Busulfan; Fludarabine; cyclosporine A and MMF

## Key facts

- **NCT ID:** NCT00427661
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427661, "A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00427661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*